AIM ImmunoTech Inc. Quarterly Costs and Expenses in USD from Q1 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
AIM ImmunoTech Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2010 to Q4 2024.
  • AIM ImmunoTech Inc. Costs and Expenses for the quarter ending December 31, 2024 was $5.9M, a 58.1% decline year-over-year.
  • AIM ImmunoTech Inc. Costs and Expenses for the twelve months ending December 31, 2024 was $19.9M, a 37.9% decline year-over-year.
  • AIM ImmunoTech Inc. annual Costs and Expenses for 2024 was $19.9M, a 37.9% decline from 2023.
  • AIM ImmunoTech Inc. annual Costs and Expenses for 2023 was $32.1M, a 60.1% increase from 2022.
  • AIM ImmunoTech Inc. annual Costs and Expenses for 2022 was $20.1M, a 5.75% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $19.9M $5.9M -$8.17M -58.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-27
Q3 2024 $28.1M $4.52M -$3.68M -44.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $31.8M $3.74M -$1.76M -32% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $33.5M $5.77M +$1.43M +32.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $32.1M $14.1M +$8.46M +151% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-27
Q3 2023 $23.7M $8.2M +$1.66M +25.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $22M $5.5M +$778K +16.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $21.2M $4.34M +$1.16M +36.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $20.1M $5.61M -$1.89M -25.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $21.9M $6.54M +$2.58M +65.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $19.4M $4.73M +$984K +26.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $18.4M $3.19M -$588K -15.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $19M $7.5M +$2.32M +44.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $16.7M $3.96M +$571K +16.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $16.1M $3.74M +$361K +10.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $15.7M $3.77M +$403K +12% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $15.3M $5.17M +$2.04M +64.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $13.3M $3.39M +$125K +3.83% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $13.2M $3.38M +$127K +3.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $13M $3.37M +$444K +15.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $12.6M $3.14M +$237K +8.17% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $12.3M $3.27M +$190K +6.18% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $12.2M $3.25M -$7K -0.22% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $12.2M $2.93M +$300K +11.4% Jan 1, 2019 Mar 31, 2019 10-Q/A 2020-05-14
Q4 2018 $11.9M $2.9M +$58K +2.04% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 $11.8M $3.08M +$334K +12.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $11.5M $3.26M +$317K +10.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $11.2M $2.63M -$699K -21% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $11.9M $2.84M -$1.26M -30.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 $13.1M $2.74M -$506K -15.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $13.6M $2.94M +$114K +4.03% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $13.5M $3.33M -$393K -10.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $13.9M $4.1M +$1.23M +42.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-30
Q3 2016 $12.7M $3.25M -$758K -18.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $13.4M $2.83M -$2.12M -42.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $15.5M $3.72M -$1.24M -25% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $16.8M $2.87M -$1.74M -37.8% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-30
Q3 2015 $18.5M $4.01M -$368K -8.41% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $18.9M $4.95M -$173K -3.38% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 $19.1M $4.96M -$229K -4.41% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 $19.3M $4.61M +$1.17M +33.8% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-31
Q3 2014 $18.1M $4.37M -$121K -2.69% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 $18.3M $5.12M +$351K +7.36% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 $17.9M $5.19M +$584K +12.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 $17.3M $3.45M -$4.6M -57.2% Oct 1, 2013 Dec 31, 2013 10-K 2014-03-14
Q3 2013 $21.9M $4.5M -$509K -10.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $22.4M $4.77M +$1.09M +29.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 $21.3M $4.6M +$785K +20.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 $20.6M $8.05M +$4.11M +104% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 $16.4M $5M +$1.4M +38.9% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 $15M $3.68M +$398K +12.1% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 $14.6M $3.82M +$187K +5.15% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 $14.5M $3.94M -$942K -19.3% Oct 1, 2011 Dec 31, 2011 10-K 2013-03-18
Q3 2011 $15.4M $3.6M -$125K -3.35% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-18
Q2 2011 $15.5M $3.28M -$526K -13.8% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-18
Q1 2011 $16M $3.63M -$473K -11.5% Jan 1, 2011 Mar 31, 2011 10-K 2013-03-18
Q4 2010 $16.5M $4.88M Oct 1, 2010 Dec 31, 2010 10-K 2013-03-18
Q3 2010 $3.73M Jul 1, 2010 Sep 30, 2010 10-K 2013-03-18
Q2 2010 $3.81M Apr 1, 2010 Jun 30, 2010 10-K 2013-03-18
Q1 2010 $4.11M Jan 1, 2010 Mar 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.